PRTN3 and rheumatoid arthritis: According to previous reports on RA, factors associated with an increased chance of remission are the absence of autoantibodies (rheumatoid factor [RF] and anti-citrullinated peptide antibody [ACPA]), younger age, male sex, shorter disease duration, rapid response to treatment, improved physical function, absence of the shared epitope, and disease activity level.